We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Valeant Revives Growth Plan With $2.6 Billion Medicis Deal
Valeant Revives Growth Plan With $2.6 Billion Medicis Deal
September 5, 2012
Valeant Pharmaceuticals’ $2.6 billion agreement to buy skin-care company Medicis Pharmaceutical recharges an acquisition plan that stumbled with last year’s failed bid for Cephalon. San Francisco Chronicle
